These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38926984)

  • 1. [Impact of Mild SARS-CoV-2 Infection on Hematological Parameters and Suitability of Apheresis Platelets Donation in Blood Donors].
    Huang SM; Lin XM; Jiang WM; Ji SH; Lin S; Lin HK; Chen C; Chu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):883-889. PubMed ID: 38926984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No increase in anti-A isohemagglutinin titer after SARS-CoV-2 infection: A retrospective cohort analysis of group O apheresis platelet donors.
    Wasiluk T; Bujno M; Rybinska K; Rogowska A; Zebrowska A; Boczkowska-Radziwon B; Piszcz J; Bolkun L; Radziwon P
    J Clin Apher; 2021 Dec; 36(6):882-885. PubMed ID: 34590725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Hematological Indices and Lymphocyte Subsets in Response to Platelet Apheresis Donation.
    Borai A; Bahijri S; Almohammadi M; Al-Sofyani A; Baljoon D; Al-Amri A; Boraie S; Ferns G
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of hematological parameters on admission in COVID-19 Omicron variant infected in Chinese population: a large-scale retrospective study.
    Xia W; Jiang T; Tan Y; Li C; Wu S; Mei B
    BMC Infect Dis; 2023 Nov; 23(1):835. PubMed ID: 38012548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.
    de Farias CLG; Bassolli L; Mendrone-Junior A; de Araújo Arrais C; Duran A; Rocha V; de Almeida-Neto C
    Transfus Apher Sci; 2022 Aug; 61(4):103424. PubMed ID: 35346602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters.
    Wang C; Deng R; Gou L; Fu Z; Zhang X; Shao F; Wang G; Fu W; Xiao J; Ding X; Li T; Xiao X; Li C
    Ann Transl Med; 2020 May; 8(9):593. PubMed ID: 32566620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Frequency of Platelet Apheresis on Coagulation Function in Donors: A Prospective Cohort Study.
    Feng Q; Zhu F; Li C; Guo B; Ye J; Chen J
    Indian J Hematol Blood Transfus; 2019 Oct; 35(4):736-741. PubMed ID: 31741630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pre- and post-donation platelet function in plateletpheresis donors.
    Zhou Q; Yu X; Cai Y; Liu L
    Transfus Clin Biol; 2017 Nov; 24(4):417-421. PubMed ID: 28599950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study.
    Ravula U; Chunchu SR; Mooli S; Naik R; Sarangapati PRR
    Transfus Clin Biol; 2022 May; 29(2):107-111. PubMed ID: 35167958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients.
    Kilercik M; Demirelce Ö; Serdar MA; Mikailova P; Serteser M
    PLoS One; 2021; 16(8):e0254073. PubMed ID: 34351940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India.
    Ojha S; Gupta AM; Nagaraju P; Poojary M; S H S
    Transfus Apher Sci; 2020 Oct; 59(5):102868. PubMed ID: 32646793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective.
    Nomani L; Raina TR; Sidhu M
    Transfus Apher Sci; 2013 Jun; 48(3):341-3. PubMed ID: 23643473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.
    Rahmani M; Fortin BM; Berliner N; Issa N; Neuberg D; Kaufman RM; Gansner JM
    Transfusion; 2019 May; 59(5):1644-1647. PubMed ID: 30747442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hematological parameters post plateletpheresis: Single center study from North India.
    Rajput S; Makroo RN; Chowdhry M; Thakur UK
    Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.